Chronic Obstructive Pulmonary Disease and Its Acute Exacerbation before Colon Adenocarcinoma Treatment Are Associated with Higher Mortality: A Propensity Score-Matched, Nationwide, Population-Based Cohort Study

Purpose: To investigate whether chronic obstructive pulmonary disease (COPD) and COPD severity (acute exacerbation of COPD (AECOPD)) affect the survival outcomes of patients with colon adenocarcinoma receiving standard treatments. Methods: From the Taiwan Cancer Registry Database, we recruited patie...

Full description

Bibliographic Details
Main Authors: Yen-Chang Chen, Ming-Chang Li, Ying-Hui Yu, Chih-Ming Lin, Szu-Yuan Wu
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/13/18/4728
id doaj-fcd1fa4a5c3740d198b6f76e533a7dc8
record_format Article
spelling doaj-fcd1fa4a5c3740d198b6f76e533a7dc82021-09-25T23:50:40ZengMDPI AGCancers2072-66942021-09-01134728472810.3390/cancers13184728Chronic Obstructive Pulmonary Disease and Its Acute Exacerbation before Colon Adenocarcinoma Treatment Are Associated with Higher Mortality: A Propensity Score-Matched, Nationwide, Population-Based Cohort StudyYen-Chang Chen0Ming-Chang Li1Ying-Hui Yu2Chih-Ming Lin3Szu-Yuan Wu4Division of Chest Medicine, Department of Internal Medicine, Lo-Hsu Medical Foundation, Lotung Poh-Ai Hospital, Yilan 256, TaiwanDepartment of Colorectal Surgery, Lo-Hsu Medical Foundation, Lotung Poh-Ai Hospital, Yilan 256, TaiwanDepartment of Colorectal Surgery, Lo-Hsu Medical Foundation, Lotung Poh-Ai Hospital, Yilan 256, TaiwanDivision of Thoracic Surgery, Department of Surgery, Lo-Hsu Medical Foundation, Lotung Poh-Ai Hospital, Yilan 256, TaiwanDepartment of Food Nutrition and Health Biotechnology, College of Medical and Health Science, Asia University, Taichung 413, TaiwanPurpose: To investigate whether chronic obstructive pulmonary disease (COPD) and COPD severity (acute exacerbation of COPD (AECOPD)) affect the survival outcomes of patients with colon adenocarcinoma receiving standard treatments. Methods: From the Taiwan Cancer Registry Database, we recruited patients with clinical stage I–III colon adenocarcinoma who had received surgery. The Cox proportional hazards model was used to analyze all-cause mortality. We categorized the patients into COPD and non-COPD (Group 1 and 2) groups through propensity score matching. Results: In total, 1512 patients were eligible for further comparative analysis between non-COPD (1008 patients) and COPD (504 patients) cohorts. In the multivariate Cox regression analysis, the adjusted hazard ratio (aHR; 95% confidence interval (CI)) for all-cause mortality for Group 1 compared with Group 2 was 1.17 (1.03, 1.29). In patients with colon adenocarcinoma undergoing curative resection, the aHRs (95% CIs) for all-cause mortality in patients with hospitalization frequencies of ≥1 and ≥2 times for AECOPD within 1 year before adenocarcinoma diagnosis were 1.08 (1.03, 1.51) and 1.55 (1.15, 2.09), respectively, compared with those without AECOPD. Conclusion: In patients with colon adenocarcinoma undergoing curative resection, COPD was associated with worse survival outcomes. Being hospitalized at least once for AECOPD within 1 year before colon adenocarcinoma diagnosis was an independent risk factor for poor overall survival in these patients, and a higher number of hospitalizations for AECOPD within 1 year before diagnosis was associated with poorer survival. Our study highlights the importance of COPD management, particularly the identification of frequent exacerbators and the prevention of AECOPD before standard colon adenocarcinoma treatments are applied.https://www.mdpi.com/2072-6694/13/18/4728colonadenocarcinomaCOPDAECOPDall-cause mortality
collection DOAJ
language English
format Article
sources DOAJ
author Yen-Chang Chen
Ming-Chang Li
Ying-Hui Yu
Chih-Ming Lin
Szu-Yuan Wu
spellingShingle Yen-Chang Chen
Ming-Chang Li
Ying-Hui Yu
Chih-Ming Lin
Szu-Yuan Wu
Chronic Obstructive Pulmonary Disease and Its Acute Exacerbation before Colon Adenocarcinoma Treatment Are Associated with Higher Mortality: A Propensity Score-Matched, Nationwide, Population-Based Cohort Study
Cancers
colon
adenocarcinoma
COPD
AECOPD
all-cause mortality
author_facet Yen-Chang Chen
Ming-Chang Li
Ying-Hui Yu
Chih-Ming Lin
Szu-Yuan Wu
author_sort Yen-Chang Chen
title Chronic Obstructive Pulmonary Disease and Its Acute Exacerbation before Colon Adenocarcinoma Treatment Are Associated with Higher Mortality: A Propensity Score-Matched, Nationwide, Population-Based Cohort Study
title_short Chronic Obstructive Pulmonary Disease and Its Acute Exacerbation before Colon Adenocarcinoma Treatment Are Associated with Higher Mortality: A Propensity Score-Matched, Nationwide, Population-Based Cohort Study
title_full Chronic Obstructive Pulmonary Disease and Its Acute Exacerbation before Colon Adenocarcinoma Treatment Are Associated with Higher Mortality: A Propensity Score-Matched, Nationwide, Population-Based Cohort Study
title_fullStr Chronic Obstructive Pulmonary Disease and Its Acute Exacerbation before Colon Adenocarcinoma Treatment Are Associated with Higher Mortality: A Propensity Score-Matched, Nationwide, Population-Based Cohort Study
title_full_unstemmed Chronic Obstructive Pulmonary Disease and Its Acute Exacerbation before Colon Adenocarcinoma Treatment Are Associated with Higher Mortality: A Propensity Score-Matched, Nationwide, Population-Based Cohort Study
title_sort chronic obstructive pulmonary disease and its acute exacerbation before colon adenocarcinoma treatment are associated with higher mortality: a propensity score-matched, nationwide, population-based cohort study
publisher MDPI AG
series Cancers
issn 2072-6694
publishDate 2021-09-01
description Purpose: To investigate whether chronic obstructive pulmonary disease (COPD) and COPD severity (acute exacerbation of COPD (AECOPD)) affect the survival outcomes of patients with colon adenocarcinoma receiving standard treatments. Methods: From the Taiwan Cancer Registry Database, we recruited patients with clinical stage I–III colon adenocarcinoma who had received surgery. The Cox proportional hazards model was used to analyze all-cause mortality. We categorized the patients into COPD and non-COPD (Group 1 and 2) groups through propensity score matching. Results: In total, 1512 patients were eligible for further comparative analysis between non-COPD (1008 patients) and COPD (504 patients) cohorts. In the multivariate Cox regression analysis, the adjusted hazard ratio (aHR; 95% confidence interval (CI)) for all-cause mortality for Group 1 compared with Group 2 was 1.17 (1.03, 1.29). In patients with colon adenocarcinoma undergoing curative resection, the aHRs (95% CIs) for all-cause mortality in patients with hospitalization frequencies of ≥1 and ≥2 times for AECOPD within 1 year before adenocarcinoma diagnosis were 1.08 (1.03, 1.51) and 1.55 (1.15, 2.09), respectively, compared with those without AECOPD. Conclusion: In patients with colon adenocarcinoma undergoing curative resection, COPD was associated with worse survival outcomes. Being hospitalized at least once for AECOPD within 1 year before colon adenocarcinoma diagnosis was an independent risk factor for poor overall survival in these patients, and a higher number of hospitalizations for AECOPD within 1 year before diagnosis was associated with poorer survival. Our study highlights the importance of COPD management, particularly the identification of frequent exacerbators and the prevention of AECOPD before standard colon adenocarcinoma treatments are applied.
topic colon
adenocarcinoma
COPD
AECOPD
all-cause mortality
url https://www.mdpi.com/2072-6694/13/18/4728
work_keys_str_mv AT yenchangchen chronicobstructivepulmonarydiseaseanditsacuteexacerbationbeforecolonadenocarcinomatreatmentareassociatedwithhighermortalityapropensityscorematchednationwidepopulationbasedcohortstudy
AT mingchangli chronicobstructivepulmonarydiseaseanditsacuteexacerbationbeforecolonadenocarcinomatreatmentareassociatedwithhighermortalityapropensityscorematchednationwidepopulationbasedcohortstudy
AT yinghuiyu chronicobstructivepulmonarydiseaseanditsacuteexacerbationbeforecolonadenocarcinomatreatmentareassociatedwithhighermortalityapropensityscorematchednationwidepopulationbasedcohortstudy
AT chihminglin chronicobstructivepulmonarydiseaseanditsacuteexacerbationbeforecolonadenocarcinomatreatmentareassociatedwithhighermortalityapropensityscorematchednationwidepopulationbasedcohortstudy
AT szuyuanwu chronicobstructivepulmonarydiseaseanditsacuteexacerbationbeforecolonadenocarcinomatreatmentareassociatedwithhighermortalityapropensityscorematchednationwidepopulationbasedcohortstudy
_version_ 1717367807414370304